NDEL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.341400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.839000E-01
Normal-vs-Stage2
5.775200E-03
Normal-vs-Stage3
8.225400E-01
Normal-vs-Stage4
2.808600E-01
Stage1-vs-Stage2
9.036800E-01
Stage1-vs-Stage3
5.296800E-01
Stage1-vs-Stage4
4.083000E-01
Stage2-vs-Stage3
4.056400E-01
Stage2-vs-Stage4
3.278800E-01
Stage3-vs-Stage4
2.845800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.758800E-03
Normal-vs-AfricanAmerican
1.146160E-01
Normal-vs-Asian
8.092600E-01
Caucasian-vs-AfricanAmerican
6.077000E-01
Caucasian-vs-Asian
4.766000E-01
AfricanAmerican-vs-Asian
3.676800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.889800E-02
Normal-vs-Female
4.015000E-03
Male-vs-Female
2.845400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.539800E-01
Normal-vs-Age(41-60Yrs)
1.62559999999923E-05
Normal-vs-Age(61-80Yrs)
2.720200E-01
Normal-vs-Age(81-100Yrs)
7.627600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.591400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.720200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.232200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.582060E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.768100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.317000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.210600E-01
Normal-vs-Daily Drinker
8.639600E-01
Normal-vs-Weekly Drinker
1.433610E-01
Normal-vs-Occasional Drinker
1.346370E-01
Normal-vs-Social Drinker
7.462300E-02
Non Drinker-vs-Daily Drinker
7.022200E-01
Non Drinker-vs-Weekly Drinker
3.789600E-01
Non Drinker-vs-Occasional Drinker
6.481800E-01
Non Drinker-vs-Social Drinker
3.291200E-01
Daily Drinker-vs-Weekly Drinker
1.801020E-01
Daily Drinker-vs-Occasional Drinker
3.184600E-01
Daily Drinker-vs-Social Drinker
1.303790E-01
Weekly Drinker-vs-Occasional Drinker
5.670600E-01
Weekly Drinker-vs-Social Drinker
9.758000E-01
Occasional Drinker-vs-Social Drinker
4.978400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.392400E-01
Normal-vs-Grade 2
9.088200E-01
Normal-vs-Grade 3
9.087000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.625000E-01
Grade 1-vs-Grade 3
6.398400E-01
Grade 1-vs-Grade 4
9.392400E-01
Grade 2-vs-Grade 3
9.959200E-01
Grade 2-vs-Grade 4
9.088200E-01
Grade 3-vs-Grade 4
9.087000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.008200E-01
Normal-vs-NonDiabetic
1.175850E-02
Diabetic-vs-NonDiabetic
4.201200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.696000E-02
Normal-vs-NoPancreatitis
3.623800E-02
Pancreatitis-vs-NoPancreatitis
4.485200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.711600E-02
Normal-vs-N1
9.904100E-03
N0-vs-N1
8.176000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.687200E-01
Normal-vs-TP53-NonMutant
9.397000E-01
TP53-Mutant-vs-TP53-NonMutant
1.265200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
